About SGS

From molecule to human

Our Clinical Pharmacology Unit (SGS CPU) has been researching tomorrow's medicines for more than 40 years now. We investigate how the bodies of healthy humans respond to molecules. These are small active substances which may be able to prevent or cure numerous diseases such as headaches, heart disease and cancer in the future.

We are the crucial link in the development of new medicines, those in our medicine cabinet and those used in the medical world.

> 100



healthy pioneers
in our database


number of screening
exams conducted
in 2022

> 40 year

experience in
clinical studies

From lab to hospital

Clinical studies to investigate new medicines at SGS CPU involve an independent team of more than 100 experts: from nurses, technicians and logistics staff to doctors, pharmacists and other study-related staff. Every study is conducted by an established multidisciplinary team, each member with their own responsibilities but all focused on your health and on running the study as best and correct as possible.    

Pioneers will encounter various disciplines during the course of the study:  

  • The recruiter, who selects possible study participants or pioneers
  • The medical team including doctors and nurses who look after all the medical interventions. In fact, the doctors have ultimate responsibility for the study.
  • The coordinator maintains the overview throughout the study from screening to the final examination.

Our research centre even has its own expert laboratories and a specialist pharmacy. UZA and Antwerp University experts and university researchers are also only ever a stone's throw away.


From discovery to medicine

The activities at our research centre are part of a broad range of services we offer to the international pharmaceutical industry and biotech companies. SGS is involved in the entire clinical study process after the preclinical phase from start to finish. This process includes aspects such as developing the studydesign, writing protocols, processing collected data including statistics and drafting the final report.

The head office in Mechelen with more than 400 specialists is where all these activities are performed. Bioanalysis of samples is done at the laboratory in Wavre, where more than 200 staff members conduct analyses throughout the development and production of medicines.

SGS supports the entire process: from the promising discovery of a molecule until the realisation of a usable medicine.

Any other questions?

Ask your question